• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

15.46 -1.06 (-6.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 424,452
Open 16.52
Bid (Size) 15.36 (100)
Ask (Size) 17.00 (1,500)
Prev. Close 16.52
Today's Range 15.33 - 16.52
52wk Range 11.09 - 23.00
Shares Outstanding 25,688,062
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eton Pharma (ETON) Q3 2025 Earnings Transcript ↗
November 09, 2025
Eton Pharma (ETON) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
ETON PHARMACEUTICALS INC (NASDAQ:ETON) Reports Q3 2025 Revenue Beat and EPS Miss ↗
November 06, 2025
Eton Pharmaceuticals Q3 2025 results: A mixed quarter with a 7.6% revenue beat but a miss on earnings per share. 
Via Chartmill

Performance

YTD
-4.9%
-4.9%
1 Month
-8.4%
-8.4%
3 Month
-14.5%
-14.5%
6 Month
+6.3%
+6.3%
1 Year
+15.0%
+15.0%

More News

Read More
News headline image
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
November 06, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
News headline image
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
October 23, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
News headline image
A Look Ahead: Eton Pharmaceuticals's Earnings Forecast ↗
May 12, 2025
Via Benzinga
News headline image
Eton (ETON) Q2 Revenue Jumps 108% ↗
August 07, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
August 07, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
July 08, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
June 27, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue ↗
May 29, 2025
Via Benzinga
News headline image
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
May 28, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts ↗
May 14, 2025
Via Benzinga
News headline image
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
May 13, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Earnings Scheduled For May 13, 2025 ↗
May 13, 2025
Via Benzinga
News headline image
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
May 01, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
April 28, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Evaluating ETON PHARMACEUTICALS INC (NASDAQ:ETON) using Mark Minervini’s winning stock formula ↗
April 25, 2025
Via Chartmill
News headline image
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
April 01, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
5 Analysts Assess Eton Pharmaceuticals: What You Need To Know ↗
March 19, 2025
Via Benzinga
News headline image
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
March 18, 2025
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Earnings Scheduled For March 18, 2025 ↗
March 18, 2025
Via Benzinga
News headline image
Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month, Eyes 2026 Launch ↗
March 14, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
March 14, 2025
Via Benzinga

Frequently Asked Questions

Is Eton Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Eton Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Eton Pharmaceuticals, Inc. - Common Stock trade on?
Eton Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock is ETON on the Nasdaq Stock Market
What is the current price of Eton Pharmaceuticals, Inc. - Common Stock?
The current price of Eton Pharmaceuticals, Inc. - Common Stock is 15.46
When was Eton Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Eton Pharmaceuticals, Inc. - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Eton Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Eton Pharmaceuticals, Inc. - Common Stock is 397.14M
How many shares of Eton Pharmaceuticals, Inc. - Common Stock are outstanding?
Eton Pharmaceuticals, Inc. - Common Stock has 397M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap